BIOCRYST PHARMACEUTICALS INC 4
4 · BIOCRYST PHARMACEUTICALS INC · Filed Oct 28, 2003
Insider Transaction Report
Form 4
BUGG CHARLES E
DirectorChairman
Transactions
- Exercise/Conversion
Common Stock
2003-10-24$6.00/sh+10,000$60,000→ 44,035 total - Disposition to Issuer
Stock Option
2003-10-24$2.85/sh−170,000$484,500→ 10,000 totalExercise: $6.00From: 1994-03-02Exp: 2003-11-18→ Common Stock (170,000 underlying) - Exercise/Conversion
Stock Option
2003-10-24$6.00/sh−10,000$60,000→ 0 totalExercise: $6.00From: 1994-03-02Exp: 2003-11-18→ Common Stock (10,000 underlying)
Holdings
- 73,138(indirect: By Partnership)
Common Stock
Footnotes (1)
- [F1]The option was canceled by mutual agreement of the reporting person and BioCryst Pharmaceuticals, Inc.. The reporting person received $484,500.00 as consideration for the cancellation.